We are live on ! Find out more
STOK icon

Stoke Therapeutics
STOK

90 hedge funds and large institutions have $492M invested in Stoke Therapeutics in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 30 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.4% less ownership

Funds ownership: 55.07% → 52.67% (-2.4%)

7% less funds holding

Funds holding: 97 → 90 (-7)

13% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 30

28% less capital invested

Capital invested by funds: $680M → $492M (-$188M)

47% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 15

55% less call options, than puts

Call options by funds: $336K | Put options by funds: $745K

Holders
90
Holders Change
-7
Holders Change %
-7.22%
% of All Funds
1.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
26
Reduced
30
Closed
15
Calls
$336K
Puts
$745K
Net Calls
-$409K
Net Calls Change
-$1.04M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$8.96M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$3.03M
3
TCM
Tekla Capital Management
Massachusetts
+$2.77M
4
Millennium Management
Millennium Management
New York
+$1.53M
5
HS
HighVista Strategies
Massachusetts
+$1.33M

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$22.6M
2
SFM
Sphera Funds Management
Israel
-$7.85M
3
GGHC
Gilder Gagnon Howe & Co
New York
-$3.42M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$3.26M
5
BlackRock
BlackRock
New York
-$2.85M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$1.52M +$155K +5,565 +10%
Millennium Management
27
Millennium Management
New York
$1.4M +$1.53M +54,825 New
Victory Capital Management
28
Victory Capital Management
Texas
$1.36M -$138K -4,956 -8%
HS
29
HighVista Strategies
Massachusetts
$1.21M +$1.33M +47,594 New
Norges Bank
30
Norges Bank
Norway
$1.15M +$1.26M +45,200 New
AA
31
ALPS Advisors
Colorado
$1.15M -$92.5K -3,317 -7%
Dimensional Fund Advisors
32
Dimensional Fund Advisors
Texas
$1.14M -$1.69M -60,664 -58%
SG Americas Securities
33
SG Americas Securities
New York
$1.06M +$689K +24,697 +144%
Citigroup
34
Citigroup
New York
$1.01M -$802K -28,749 -42%
CAC
35
Cowen and Company
New York
$913K +$1M +35,899 New
UBS Group
36
UBS Group
Switzerland
$835K +$797K +28,571 +674%
Rafferty Asset Management
37
Rafferty Asset Management
New York
$827K -$7.75K -278 -0.8%
Citadel Advisors
38
Citadel Advisors
Florida
$747K -$830K -29,765 -50%
TD Asset Management
39
TD Asset Management
Ontario, Canada
$741K – – –
Swiss National Bank
40
Swiss National Bank
Switzerland
$717K – – –
Deutsche Bank
41
Deutsche Bank
Germany
$693K +$408K +14,628 +116%
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$535K +$268K +9,606 +84%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$530K -$154K -5,507 -21%
Los Angeles Capital Management
44
Los Angeles Capital Management
California
$511K +$82.8K +2,970 +17%
AllianceBernstein
45
AllianceBernstein
Tennessee
$473K -$33.5K -1,200 -6%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$466K +$23.7K +849 +5%
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$440K – – –
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$422K +$2.62K +94 +0.6%
BNP Paribas Financial Markets
49
BNP Paribas Financial Markets
France
$412K +$432K +15,492 +2,182%
BC
50
Birchview Capital
Vermont
$382K – – –
1
2
3 4 5

STOK Hedge Fund Activity: Q3 2021 in Review

90 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Stoke Therapeutics (STOK) for Q3 2021, worth a combined $492M — down 28% from $680M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of STOK and 8 opened new positions — a net loss of 7 holders — while 30 trimmed existing stakes and 26 added.

The largest buyer was Fidelity Investments, adding an estimated $8.96M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $22.6M sold.

  • 90 institutional investors held Stoke Therapeutics (STOK) as of Q3 2021, down from 97 in Q2 2021.
  • Funds reported $492M of Stoke Therapeutics stock for Q3 2021, down 28% quarter-over-quarter.
  • 8 funds opened new Stoke Therapeutics positions in Q3 2021 and 15 closed out, a net change of -7 holders.
  • The largest Stoke Therapeutics buyer in Q3 2021 was Fidelity Investments, an estimated $8.96M added.
  • The largest Stoke Therapeutics seller in Q3 2021 was Perceptive Advisors, an estimated $22.6M sold.

Based on aggregated 13F filings for Q3 2021.